Waverley Pharma Inc. WAVE.V Stock
Waverley Pharma Inc. Price Chart
Waverley Pharma Inc. WAVE.V Financial and Trading Overview
| Waverley Pharma Inc. stock price | 0.04 CAD |
| Previous Close | 0.04 CAD |
| Open | 0.04 CAD |
| Bid | 0.02 CAD x 0 |
| Ask | 0.05 CAD x 0 |
| Day's Range | 0.04 - 0.04 CAD |
| 52 Week Range | 0.03 - 0.08 CAD |
| Volume | 2K CAD |
| Avg. Volume | 1.65K CAD |
| Market Cap | 1.89M CAD |
| Beta (5Y Monthly) | 1.328523 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10 CAD |
WAVE.V Valuation Measures
| Enterprise Value | 2.54M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.7803131 |
| Price/Book (mrq) | 2.5 |
| Enterprise Value/Revenue | 2.394 |
| Enterprise Value/EBITDA | -2.793 |
Trading Information
Waverley Pharma Inc. Stock Price History
| Beta (5Y Monthly) | 1.328523 |
| 52-Week Change | -41.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 CAD |
| 52 Week Low | 0.03 CAD |
| 50-Day Moving Average | 0.03 CAD |
| 200-Day Moving Average | 0.04 CAD |
WAVE.V Share Statistics
| Avg. Volume (3 month) | 1.65K CAD |
| Avg. Daily Volume (10-Days) | 0 CAD |
| Shares Outstanding | 54M |
| Float | 13.61M |
| Short Ratio | 0.03 |
| % Held by Insiders | 74.79% |
| % Held by Institutions | 0% |
| Shares Short | 74 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -65.24% |
| Operating Margin (ttm) | -102.66% |
| Gross Margin | 21.60% |
| EBITDA Margin | -85.71% |
Management Effectiveness
| Return on Assets (ttm) | -24.089% |
| Return on Equity (ttm) | -59.13% |
Income Statement
| Revenue (ttm) | 1.06M CAD |
| Revenue Per Share (ttm) | 0.02 CAD |
| Quarterly Revenue Growth (yoy) | -60.89% |
| Gross Profit (ttm) | N/A |
| EBITDA | -909987 CAD |
| Net Income Avi to Common (ttm) | -692644 CAD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 135.12K CAD |
| Total Cash Per Share (mrq) | 0.003 CAD |
| Total Debt (mrq) | 786.86K CAD |
| Total Debt/Equity (mrq) | 105.31 CAD |
| Current Ratio (mrq) | 0.314 |
| Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -470181 CAD |
| Levered Free Cash Flow (ttm) | -593284 CAD |
Profile of Waverley Pharma Inc.
| Country | Canada |
| State | MB |
| City | Winnipeg |
| Address | 4-1250 Waverley Street |
| ZIP | R3T 6C6 |
| Phone | 204-928-7907 |
| Website | https://www.waverleypharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib. Its products under development include injectable generic chemotherapy drugs, such as Pemetrexed for the treatment of non-small cell lung cancer and other indications; and Bortezomib to treat multiple myeloma and other indications. Waverley Pharma Inc. is headquartered in Winnipeg, Canada.
Q&A For Waverley Pharma Inc. Stock
What is a current WAVE.V stock price?
Waverley Pharma Inc. WAVE.V stock price today per share is 0.04 CAD.
How to purchase Waverley Pharma Inc. stock?
You can buy WAVE.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Waverley Pharma Inc.?
The stock symbol or ticker of Waverley Pharma Inc. is WAVE.V.
Which industry does the Waverley Pharma Inc. company belong to?
The Waverley Pharma Inc. industry is Biotechnology.
How many shares does Waverley Pharma Inc. have in circulation?
The max supply of Waverley Pharma Inc. shares is 54M.
What is Waverley Pharma Inc. Price to Earnings Ratio (PE Ratio)?
Waverley Pharma Inc. PE Ratio is now.
What was Waverley Pharma Inc. earnings per share over the trailing 12 months (TTM)?
Waverley Pharma Inc. EPS is -0.02 CAD over the trailing 12 months.
Which sector does the Waverley Pharma Inc. company belong to?
The Waverley Pharma Inc. sector is Healthcare.